drugset / Trial / NCT02304705

Sildenafil in Heart Failure With Reactive Pulmonary Hypertension

NCT02304705

Phase 4 Terminated 33 enrolled Maya Guglin
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether Sildenafil 20mg taken three times a day is effective in the treatment of Heart Failure with Reactive Pulmonary Hypertension. This is a double-blind, placebo controlled trial.

Timeline

Start
2015-01
Primary completion
2017-06
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sildenafil Unknown 20 mg Oral